Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Krystal Herline, Eleanor Drummond & Thomas Wisniewski. (2018) Recent advancements toward therapeutic vaccines against Alzheimer’s disease. Expert Review of Vaccines 17:8, pages 707-721.
Read now
Read now
Yun-Zhou Yu & Qing Xu. (2016) Prophylactic immunotherapy of Alzheimer's disease using recombinant amyloid-β B-cell epitope chimeric protein as subunit vaccine. Human Vaccines & Immunotherapeutics 12:11, pages 2801-2804.
Read now
Read now
Articles from other publishers (45)
Soumya Kandi, Erika N. Cline, Brianna M. Rivera, Kirsten L. Viola, Jiuhe Zhu, Carlo Condello, Richard D. LeDuc, William L. Klein, Neil L. Kelleher & Steven M. Patrie. (2023) Amyloid β Proteoforms Elucidated by Quantitative LC/MS in the 5xFAD Mouse Model of Alzheimer’s Disease. Journal of Proteome Research 22:11, pages 3475-3488.
Crossref
Crossref
Ye Wu, Li Fu, Qianqian Li, Xiang Gao, Yingjun Zhang, Chuanfei Jin, Feiqing Ding, Sheng Hong, Hui Cai & Yiliang Li. (2023) Recent Advancements in the Early Diagnosis and Treatment of Alzheimer's Disease. Advanced Therapeutics 6:11.
Crossref
Crossref
Zachary Valiukas, Ramya Ephraim, Kathy Tangalakis, Majid Davidson, Vasso Apostolopoulos & Jack Feehan. (2022) Immunotherapies for Alzheimer’s Disease—A Review. Vaccines 10:9, pages 1527.
Crossref
Crossref
Dominika Nowak, Wojciech Słupski & Maria Rutkowska. (2021) Nowe strategie terapeutyczne choroby Alzheimera. Postępy Higieny i Medycyny Doświadczalnej 75:1, pages 474-490.
Crossref
Crossref
Virgil Schijns, Alberto Fernández‐Tejada, Žarko Barjaktarović, Ilias Bouzalas, Jens Brimnes, Sergey Chernysh, Sveinbjorn Gizurarson, Ihsan Gursel, Žiga Jakopin, Maria Lawrenz, Cristina Nativi, Stephane Paul, Gabriel Kristian Pedersen, Camillo Rosano, Ane Ruiz‐de‐Angulo, Bram Slütter, Aneesh Thakur, Dennis Christensen & Ed C. Lavelle. (2020) Modulation of immune responses using adjuvants to facilitate therapeutic vaccination. Immunological Reviews 296:1, pages 169-190.
Crossref
Crossref
Md. Tanvir Kabir, Md. Sahab Uddin, Bijo Mathew, Pankoj Kumar Das, Asma Perveen & Ghulam Md. Ashraf. (2020) Emerging Promise of Immunotherapy for Alzheimer’s Disease: A New Hope for the Development of Alzheimer’s Vaccine. Current Topics in Medicinal Chemistry 20:13, pages 1214-1234.
Crossref
Crossref
Mei Ji, Xi-xiu Xie, Dong-qun Liu, Shuai Lu, Ling-xiao Zhang, Ya-ru Huang & Rui-tian Liu. (2020) Engineered hepatitis B core virus-like particle carrier for precise and personalized Alzheimer’s disease vaccine preparation via fixed-point coupling. Applied Materials Today 19, pages 100575.
Crossref
Crossref
Juan García-Arriaza, María Q. Marín, Jesús Merchán-Rubira, Sara M. Mascaraque, Miguel Medina, Jesús Ávila, Félix Hernández & Mariano Esteban. (2020) Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized with DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins. Vaccines 8:1, pages 127.
Crossref
Crossref
Gayane Hrachia Buniatian, Ralf Weiskirchen, Thomas S. Weiss, Ute Schwinghammer, Martin Fritz, Torgom Seferyan, Barbara Proksch, Michael Glaser, Ali Lourhmati, Marine Buadze, Erawan Borkham-Kamphorst, Frank Gaunitz, Christoph H. Gleiter, Thomas Lang, Elke Schaeffeler, Roman Tremmel, Holger Cynis, William H. FreyIIII, Rolf Gebhardt, Scott L. Friedman, Wolfgang Mikulits, Matthias Schwab & Lusine Danielyan. (2020) Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver. Cells 9:2, pages 452.
Crossref
Crossref
Fu-Qiang Zhang, Jin-Lan Jiang, Jing-Tian Zhang, Han Niu, Xue-Qi Fu & Lin-Lin Zeng. (2020) Current status and future prospects of stem cell therapy in Alzheimer’s disease. Neural Regeneration Research 15:2, pages 242.
Crossref
Crossref
Paul C. Guest. 2020. Clinical and Preclinical Models for Maximizing Healthspan. Clinical and Preclinical Models for Maximizing Healthspan
3
28
.
Ping Yang, Yongqing Guo, Yao Sun, Bin Yu, Haihong Zhang, Jiaxin Wu, Xianghui Yu, Hui Wu & Wei Kong. (2019) Active immunization with norovirus P particle-based amyloid-β chimeric protein vaccine induces high titers of anti-Aβ antibodies in mice. BMC Immunology 20:1.
Crossref
Crossref
Eleanor Drummond & Thomas Wisniewski. 2019. Alzheimer’s Disease. Alzheimer’s Disease
37
51
.
Marcella Catania, Giorgio Giaccone, Mario Salmona, Fabrizio Tagliavini & Giuseppe Di Fede. (2019) Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder. Frontiers in Aging Neuroscience 11.
Crossref
Crossref
Nalini Schaduangrat, Veda Prachayasittikul, Saowapak Choomwattana, Prapimpun Wongchitrat, Kamonrat Phopin, Wilasinee Suwanjang, Aijaz Ahmad Malik, Bruno Vincent & Chanin Nantasenamat. (2019) Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease. Medicinal Research Reviews 39:5, pages 1730-1778.
Crossref
Crossref
Sonja Prpar Mihevc & Gregor Majdič. (2019) Canine Cognitive Dysfunction and Alzheimer’s Disease – Two Facets of the Same Disease?. Frontiers in Neuroscience 13.
Crossref
Crossref
Mei Yu, Xuwei Chen, Jihong Liu, Quan Ma, Zhan Zhuo, Hao Chen, Lin Zhou, Sen Yang, Lifeng Zheng, Chengqing Ning, Jing Xu, Tianming Gao & Sheng-Tao Hou. (2019) Gallic acid disruption of Aβ1–42 aggregation rescues cognitive decline of APP/PS1 double transgenic mouse. Neurobiology of Disease 124, pages 67-80.
Crossref
Crossref
Chit Tam, Jack Ho Wong, Tzi Bun Ng, Stephen Kwok Wing Tsui & Tao Zuo. (2019) Drugs for Targeted Therapies of Alzheimer’s Disease. Current Medicinal Chemistry 26:2, pages 335-359.
Crossref
Crossref
D. J. Marciani. (2019) Promising Results from Alzheimer’s Disease Passive Immunotherapy Support the Development of a Preventive Vaccine. Research 2019.
Crossref
Crossref
Thomas Wisniewski & Eleanor Drummond. 2019. Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Part A. Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Part A
223
241
.
Francesca L. Guest. 2019. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders
295
317
.
Krystal Herline, Frances Prelli, Pankaj Mehta, Claire MacMurray, Fernando Goñi & Thomas Wisniewski. (2018) Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model. Alzheimer's Research & Therapy 10:1.
Crossref
Crossref
Fernando Goñi, Mitchell Martá-Ariza, Krystal Herline, Daniel Peyser, Allal Boutajangout, Pankaj Mehta, Eleanor Drummond, Frances Prelli & Thomas Wisniewski. (2018) Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer’s disease model. Alzheimer's Research & Therapy 10:1.
Crossref
Crossref
Joseph Rogers. (2018) Principles for central nervous system inflammation research: A call for a consortium approach. Alzheimer's & Dementia 14:11, pages 1553-1559.
Crossref
Crossref
Yun-Zhou Yu, Qing-Li Li, Hai-Chao Wang, Si Liu, Xiao-Bin Pang, Qing Xu, Xiao-Wei Zhou & Pei-Tang Huang. (2018) Improved synaptic and cognitive function in aged 3 × Tg-AD mice with reduced amyloid-β after immunotherapy with a novel recombinant 6Aβ15-TF chimeric vaccine. Clinical Immunology 193, pages 12-23.
Crossref
Crossref
Erin E. Congdon & Einar M. Sigurdsson. (2018) Tau-targeting therapies for Alzheimer disease. Nature Reviews Neurology 14:7, pages 399-415.
Crossref
Crossref
Eleanor Drummond, Fernando Goñi, Shan Liu, Frances Prelli, Henrieta Scholtzova & Thomas Wisniewski. (2018) Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer’s Disease. Journal of Alzheimer's Disease 64:s1, pages S299-S312.
Crossref
Crossref
Pankaj D. Mehta, Bruce A. Patrick, Marc Barshatzky, Sangita P. Mehta, Janusz Frackowiak, Bozena Mazur-Kolecka, Jerzy Wegiel, Thomas Wisniewski & David L. Miller. (2018) Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β3-42 (pE3-Aβ). Journal of Alzheimer's Disease 62:4, pages 1635-1649.
Crossref
Crossref
Ya-Ru Wen, Jun-Hua Yang, Xiao Wang & Zhi-Bin Yao. (2018) Induced dural lymphangiogenesis facilities soluble amyloid-beta clearance from brain in a transgenic mouse model of Alzheimer's disease. Neural Regeneration Research 13:4, pages 709.
Crossref
Crossref
Thomas Wisniewski & Fernando Goñi. 2018. Human Prion Diseases. Human Prion Diseases
419
430
.
Senthilkumar Krishnaswamy, Qian Wu, Yan Lin, Wajitha J. Rajamohamedsait, Hameetha B. Rajamohamedsait & Einar M. Sigurdsson. 2018. Amyloid Proteins. Amyloid Proteins
513
526
.
Charbel Moussa, Michaeline Hebron, Xu Huang, Jaeil Ahn, Robert A. Rissman, Paul S. Aisen & R. Scott Turner. (2017) Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. Journal of Neuroinflammation 14:1.
Crossref
Crossref
Yuan Meng, Li Ding, Hui-Yi Zhang, Wen-Chao Yin, Yi Yan & Yun-Peng Cao. (2017) An Aβ3-10-KLH vaccine reduced Alzheimer’s disease-like pathology and had a sustained effect in Tg-APPswe/PSEN1dE9 mice. Brain Research 1673, pages 72-77.
Crossref
Crossref
Fernando Goñi, Mitchell Martá-Ariza, Daniel Peyser, Krystal Herline & Thomas Wisniewski. (2017) Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases. Scientific Reports 7:1.
Crossref
Crossref
Yuan Meng, Li Ding, HuiYi Zhang, WenChao Yin, Yi Yan & YunPeng Cao. (2017) Immunization of Tg-APPswe/PSEN1dE9 mice with Aβ3-10-KLH vaccine prevents synaptic deficits of Alzheimer’s disease. Behavioural Brain Research 332, pages 64-70.
Crossref
Crossref
Chang Yi Wang, Pei-Ning Wang, Ming-Jang Chiu, Connie L. Finstad, Feng Lin, Shugene Lynn, Yuan-Hung Tai, Xin De Fang, Kesheng Zhao, Chung-Ho Hung, Yiting Tseng, Wen-Jiun Peng, Jason Wang, Chih-Chieh Yu, Be-Sheng Kuo & Paul A. Frohna. (2017)
UB-311, a novel UBITh
®
amyloid β peptide vaccine for mild Alzheimer's disease
. Alzheimer's & Dementia: Translational Research & Clinical Interventions 3:2, pages 262-272.
Crossref
Crossref
Rachel E. Lackie, Andrzej Maciejewski, Valeriy G. Ostapchenko, Jose Marques-Lopes, Wing-Yiu Choy, Martin L. Duennwald, Vania F. Prado & Marco A. M. Prado. (2017) The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases. Frontiers in Neuroscience 11.
Crossref
Crossref
Eric Heuer, Jessica Jacobs, Rebecca Du, Silun Wang, Orion P. Keifer, Amarallys F. Cintron, Jeromy Dooyema, Yuguang Meng, Xiaodong Zhang & Lary C. Walker. (2017) Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy. Journal of Alzheimer's Disease 57:2, pages 519-530.
Crossref
Crossref
Eleanor Drummond & Thomas Wisniewski. (2016) Alzheimer’s disease: experimental models and reality. Acta Neuropathologica 133:2, pages 155-175.
Crossref
Crossref
Henrieta Scholtzova, Eileen Do, Shleshma Dhakal, Yanjie Sun, Shan Liu, Pankaj D. Mehta & Thomas Wisniewski. (2017) Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits. The Journal of Neuroscience 37:4, pages 936-959.
Crossref
Crossref
Eleanor Drummond & Thomas Wisniewski. (2017) The use of localized proteomics to identify the drivers of Alzheimer's disease pathogenesis. Neural Regeneration Research 12:6, pages 912.
Crossref
Crossref
S. Quraishe, C.M. Cowan & A. Mudher. 2017. Neuroprotection in Alzheimer's Disease. Neuroprotection in Alzheimer's Disease
73
96
.
Asuka A. Orr, Michael M. Wördehoff, Wolfgang Hoyer & Phanourios Tamamis. (2016) Uncovering the Binding and Specificity of β-Wrapins for Amyloid-β and α-Synuclein. The Journal of Physical Chemistry B 120:50, pages 12781-12794.
Crossref
Crossref
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno P Imbimbo, Madia Lozupone, Andrea Santamato, Rosanna Tortelli, Ilaria Galizia, Camilla Prete, Antonio Daniele, Alberto Pilotto, Antonio Greco & Giancarlo Logroscino. (2016) Tau-based therapeutics for Alzheimer’s disease: active and passive immunotherapy. Immunotherapy 8:9, pages 1119-1134.
Crossref
Crossref
Eleni Konsolaki, Panagiotis Tsakanikas, Alexia V. Polissidis, Antonios Stamatakis & Irini Skaliora. (2016) Early Signs of Pathological Cognitive Aging in Mice Lacking High-Affinity Nicotinic Receptors. Frontiers in Aging Neuroscience 8.
Crossref
Crossref